EHC/LinkedIn
Apr 7, 2026, 16:44
A Call to Get the Biotech Act Right for The Millions Living with Bleeding Disorders – EHC
EHC – European Haemophilia Consortium shared on LinkedIn:
”Innovation without access is not progress.
On World Health Day, the EHC is calling on EU policymakers to get the Biotech Act right for the millions living with bleeding disorders who cannot afford to wait.
Science is moving fast.
Regulation and access must keep up.
The EHC demands:
- Patients at the table, not as an afterthought, but at every stage of research, trials, and regulatory decisions
- Real-world evidence that counts, because clinical trial data alone do not capture the full picture of patients’ lives
- Cross-border clinical trials to break down barriers and bring innovation to patients across Europe, no matter where they live
The theme of World Health Day 2026 is ‘Together for health: stand with science’.
Standing with science means ensuring that science stands for patients.
The EU Biotech Act is an opportunity. Let’s not waste it.
Stay updated with Hemostasis Today.
-
Apr 7, 2026, 16:40Pooja Choradia: Understanding Consumption Coagulopathy in Acute Pulmonary Embolism
-
Apr 7, 2026, 16:06Mohamed Elsafy։ Rethinking Hemostatic Management in Glanzmann Thrombasthenia with Sutacimig
-
Apr 7, 2026, 16:03Frits Rosendaal Is The 2026 Recipient of the ISTH Robert P. Grant Medal
-
Apr 7, 2026, 16:02Support the WHO Resolution On Stroke and Set A Clear Path to Action – World Stroke Organization
-
Apr 7, 2026, 16:00Amit Saraswat: The Role of Physiotherapy in Regaining Independence In Stroke Recovery
-
Apr 7, 2026, 15:59David Stegner: How Fundamental Platelet Research Can Translate Into Therapeutic Innovation
-
Apr 7, 2026, 15:58Armghan Ans: The 2026 Stroke Guidelines and the Clinical Logic Gap in AI Tools
-
Apr 7, 2026, 15:55Louise St. Germain Bannon: A Call to Advance Health Equity for Women on World Health Day
-
Apr 7, 2026, 15:54Emicizumab In a Preterm Infant with Severe Hemophilia A – RPTH